Cargando…
FRI616 Combined Elf5a And Notch Inhibition Reprograms The Effector T Cell Fate Decisions Towards Treg Phenotype Without Any Off Target Effect
Disclosure: S. Rafiqi: None. A. Aldasouqi: None. S. faisal: None. S. Qureshi: None. A. Mahmood: None. J.C. Jaume: None. S. Imam: None. We explored immune resetting and plasticity of T effector cells towards T regulatory cells (CD4+CD25+FOXP3+) by elF5A and Notch inhibition. We validated our approach...
Autores principales: | Imtiaz Rafiqi, Shafiya, Aldasouqi, Ahmad, faisal, sarah, Qureshi, Salauddin, Mahmood, Asif, Carlos Jaume, Juan, Imam, Shahnawaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554708/ http://dx.doi.org/10.1210/jendso/bvad114.838 |
Ejemplares similares
-
SAT102 Natural History Of Type 1 Diabetes In Humanized Mouse Model
por: Aldasouqi, Ahmad, et al.
Publicado: (2023) -
SAT052 Prolonged Nursing Augments Short Chain Fatty Acid Levels And Leads To Amelioration Of Type 1 Diabetes
por: Imtiaz rafiqi, Shafiya, et al.
Publicado: (2023) -
MON-LB033 Unleashing the Anti-Inflammatory Potential of Treg Cells Against Type I Diabetes Using Advanced Chimeric Antigen Receptor Technology
por: Imam, Shahnawaz, et al.
Publicado: (2019) -
SAT-LB036 Late Weaning Leads to Enrichment of Treg Cells Which Consequently Regulates Effector T Cell Responses in Peri-Pancreatic Lymph Nodes and Pancreas of Humanized Model T1D
por: Imam, Shahnawaz, et al.
Publicado: (2019) -
PSUN231 Adoptive Cell Transfer for Type 1 Diabetes Reversal
por: Imam, Shahnawaz, et al.
Publicado: (2022)